Improvements in Cough Frequency Over 24 Hours with BLU-5937, a Selective P2X3 Antagonist, in Patient Subgroups Defined by Baseline Awake Cough Frequencies

A6. A006 HOT TAKES FROM CLINICAL TRIALS IN LUNG DISEASE Pub Date : 1900-01-01 DOI:10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1019

J. Smith, A. Morice, S. Birring, S. Parker, P. Marsden, J. Holcomb, B. Prenner, M. Sher, G. Steven, L. Mcgarvey, D. Garceau, C. Bonuccelli, L. Harvey

引用次数: 5

查看原文本刊更多论文

BLU-5937(一种选择性P2X3拮抗剂)在基线清醒咳嗽频率定义的患者亚组中24小时咳嗽频率的改善

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

自引率

0.00%

发文量